Terms: = Sarcomas AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1 AND Treatment
13 results:
1. Cellular and Molecular Biological Alterations after Photon, Proton, and Carbon Ions Irradiation in Human Chondrosarcoma Cells Linked with High-Quality Physics Data.
Lohberger B; Barna S; Glänzer D; Eck N; Kerschbaum-Gruber S; Stasny K; Leithner A; Georg D
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232764
[TBL] [Abstract] [Full Text] [Related]
2. Rigosertib Induces Mitotic Arrest and Apoptosis in RAS-Mutated Rhabdomyosarcoma and Neuroblastoma.
Kowalczyk JT; Wan X; Hernandez ER; Luo R; Lyons GC; Wilson KM; Gallardo DC; Isanogle KA; Robinson CM; Mendoza A; Heske CM; Chen JQ; Luo X; Kelly AE; Difilippantinio S; Robey RW; Thomas CJ; Sackett DL; Morrison DK; Randazzo PA; Jenkins LMM; Yohe ME
Mol Cancer Ther; 2021 Feb; 20(2):307-319. PubMed ID: 33158997
[TBL] [Abstract] [Full Text] [Related]
3. Analyses of FGFR3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines.
Kostopoulou ON; Holzhauser S; Lange BKA; Ohmayer A; Andonova T; Bersani C; Wickström M; Dalianis T
Int J Oncol; 2019 Dec; 55(6):1372-1384. PubMed ID: 31638167
[TBL] [Abstract] [Full Text] [Related]
4. Cell-penetrating peptide-doxorubicin conjugate loaded NGR-modified nanobubbles for ultrasound triggered drug delivery.
Lin W; Xie X; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
J Drug Target; 2016; 24(2):134-46. PubMed ID: 26176270
[TBL] [Abstract] [Full Text] [Related]
5. HSP90 inhibition as a means of radiosensitizing resistant, aggressive soft tissue sarcomas.
Ernst A; Anders H; Kapfhammer H; Orth M; Hennel R; Seidl K; Winssinger N; Belka C; Unkel S; Lauber K
Cancer Lett; 2015 Sep; 365(2):211-22. PubMed ID: 26044951
[TBL] [Abstract] [Full Text] [Related]
6. Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma.
Ji WP; He NB
Int J Clin Exp Pathol; 2015; 8(1):894-9. PubMed ID: 25755792
[TBL] [Abstract] [Full Text] [Related]
7. Different impact of anti-retroviral regimen containing protease inhibitors on development of HIV-related Kaposi sarcoma.
Carleo MA; Di Martino F; Del Giudice A; Gargiulo M; Parrella G; Rosario P; Sangiovanni V; Viglietti R; Esposito V; Chirianni A
In Vivo; 2015; 29(1):133-6. PubMed ID: 25600542
[TBL] [Abstract] [Full Text] [Related]
8. Genetic variability of DNA repair mechanisms and glutathione-S-transferase genes influences treatment outcome in osteosarcoma.
Goričar K; Kovač V; Jazbec J; Zakotnik B; Lamovec J; Dolžan V
Cancer Epidemiol; 2015 Apr; 39(2):182-8. PubMed ID: 25592234
[TBL] [Abstract] [Full Text] [Related]
9. The Mre11 nuclease is critical for the sensitivity of cells to Chk1 inhibition.
Thompson R; Montano R; Eastman A
PLoS One; 2012; 7(8):e44021. PubMed ID: 22937147
[TBL] [Abstract] [Full Text] [Related]
10. p53 and p21(Waf1) are recruited to distinct PML-containing nuclear foci in irradiated and Nutlin-3a-treated U2OS cells.
Shen H; Maki CG
J Cell Biochem; 2010 Dec; 111(5):1280-90. PubMed ID: 20803550
[TBL] [Abstract] [Full Text] [Related]
11. Lack of p53 augments thymoquinone-induced apoptosis and caspase activation in human osteosarcoma cells.
Roepke M; Diestel A; Bajbouj K; Walluscheck D; Schonfeld P; Roessner A; Schneider-Stock R; Gali-Muhtasib H
Cancer Biol Ther; 2007 Feb; 6(2):160-9. PubMed ID: 17218778
[TBL] [Abstract] [Full Text] [Related]
12. The first molecular details of ALT in human tumor cells.
Muntoni A; Reddel RR
Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R191-6. PubMed ID: 16244317
[TBL] [Abstract] [Full Text] [Related]
13. A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging.
Adachi Y; Reynolds PN; Yamamoto M; Wang M; Takayama K; Matsubara S; Muramatsu T; Curiel DT
Cancer Res; 2001 Nov; 61(21):7882-8. PubMed ID: 11691808
[TBL] [Abstract] [Full Text] [Related]